(a) whether the Government has the control over the Multi-National Companies (MNCs)
in the production of essential drugs;
(b) if so, the details thereof ;and
(c) the steps taken by the Government to monitor production and availability of essential
drugs and bulk drugs?
MINISTER OF STATE (INDEPENDENT CHARGE) IN THE MINISTRY OF CHEMICALS AND FERTILIZERS AND
MINISTER OF STATE (INDEPENDENT CHARGE) IN THE MINISTRY OF STATISTICS AND PROGRAMME
IMPLEMENTATION (SHRI SRIKANT KUMAR JENA)
(a) to (c) The Department of Pharmaceuticals has notified the National Pharmaceutical Pricing
Policy-2012 on 07.12.2012. The salient features of National Pharmaceutical Pricing Policy, 2012
(NPPP-2012) are as under:
# The regulation of prices of drugs is on the basis of essentiality of drugs as specified under
National List of Essential Medicines (NLEM)-2011.
# The regulation of prices of drugs is on the basis of regulating the prices of formulations
only.
# The regulation of prices of drugs is on the basis of fixing the ceiling price of formulations
through Market Based Pricing (MBP).